Acasti Pharma Inc (ACST) stock has fallen -76.43% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ACST stock a score of 32 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 12. ACST's rank also includes a long-term technical score of 12. The fundamental score for ACST is 73. In addition to the average rating from Wall Street analysts, ACST stock has a mean target price of $6.00. This means analysts expect the stock to climb 354.55% over the next 12 months.
ACST has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ACST!
Acasti Pharma Inc (ACST) stock is trading at $1.32 as of 11:09 AM on Tuesday, Jan 11, a gain of $0.04, or 2.73% from the previous closing price of $1.28. The stock has traded between $1.25 and $1.34 so far today. Volume today is below average. So far 192,707 shares have traded compared to average volume of 2,887,611 shares.
Click Here to get the full Stock Report for Acasti Pharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
